AFTER decades of trying, pharmaceutical companies in Japan and the US have released the findings of a trial that was praised as a new discovery.
Data from Japanese and American pharmaceuticals demonstrated how a new drug can significantly prevent Alzheimer’s patients from degenerating further.
It was found that the drug reduced slow cognitive decline by 27% compared with a placebo in people with Alzheimer’s disease, which is the most common form of dementia.
About 1,800 individuals in the early stages of the illness took part in the 18-month trial.
According to Dr Donald Weaver, who is a senior scientist at Krembil Brain Institute from University Health Network in Ontario, Canada, this is probably the first drug that has ever shown the ability to affect the natural history of Alzheimer’s disease.
There is a protein in the brain called amyloid, which is a small protein, and it abnormally collects there in individuals with Alzheimer’s disease.
This protein tends to get sticky and clumps up, and when it clumps up it starts to destroy brain cells which ultimately leads to dementia.
This is a drug that attacks this particular protein and does its best to prevent the amyloid from attempting to damage the brain.
However, the medications do have some unwanted side effects, some of which may be quite serious, such as mild brain swelling and bleeding.
The first significant trial has been published and while some people believe the side effects may be related to the drug, others disagree.

[Read More…]

By clicking submit, I authorize Fitness Journal Edu and its affiliated companies to: (1) use, sell, and share my information for marketing purposes, including cross-context behavioral advertising, as described in our Terms of Service and Privacy Policy, (2) supplement the information that I provide with additional information lawfully obtained from other sources, like demographic data from public sources, interests inferred from web page views, or other data relevant to what might interest me, like past purchase or location data, (3) contact me or enable others to contact me by email with offers for goods and services from any category at the email address provided, and (4) retain my information while I am engaging with marketing messages that I receive and for a reasonable amount of time thereafter. I understand I can opt out at any time through an email that I receive, or by clicking here

© Copyrights 2024, Fitness Journal Edu. All Rights Reserved

Skip to content